Laboratoires Euromedis Société anonyme (EPA: ALEMG)

ALEMG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	18.84	26.8	31.86	15.74	5.12
Short-Term Investments	18.66	-	-	-	-	-
Cash & Short-Term Investments	18.66	18.84	26.8	31.86	15.74	5.12
Cash Growth	-15.82%	-29.69%	-15.88%	102.48%	207.50%	245.04%
Accounts Receivable	8.89	8.51	8.85	14.04	24.07	16.93
Other Receivables	0.72	1.08	2.29	5.12	3.59	1.18
Receivables	9.6	9.59	11.14	19.15	27.66	18.11
Inventory	10.05	10.81	12.59	11.76	25.71	18.16
Prepaid Expenses	0.11	0.06	0.18	0.16	0.2	0.23
Other Current Assets	0.21	0	1.17	1.47	14	0.11
Total Current Assets	38.63	39.3	51.87	64.41	83.3	42.42
Property, Plant & Equipment	0.55	0.63	4.32	4.4	4.27	5.28
Long-Term Investments	-	6.21	0.88	0.9	0.91	1.03
Goodwill	-	-	2.54	2.63	3.72	4.72
Other Intangible Assets	0.02	0.03	0.09	0.14	0.13	0.28
Other Long-Term Assets	6.27	0.09	0.16	0.25	0.24	0.2
Total Assets	45.47	46.26	59.87	72.72	92.62	53.98
Accounts Payable	8.62	7.81	7.31	10.5	20.65	12.53
Accrued Expenses	1.04	-	1.61	1.86	7.13	4.28
Short-Term Debt	0	-	0	0.54	1.3	12.91
Current Portion of Long-Term Debt	2.75	4.93	-	-	-	-
Current Income Taxes Payable	-	1.1	-	-	4.24	-
Current Unearned Revenue	-	-	0.03	0.21	-	-
Other Current Liabilities	1.43	1.41	0.52	0.31	0.18	0.23
Total Current Liabilities	13.84	15.25	9.48	13.42	33.49	29.94
Long-Term Debt	6.28	5.09	12.73	14.63	16.05	6.56
Long-Term Leases	-	-	0.11	0.36	0.41	0.55
Long-Term Unearned Revenue	-	-	0.07	0.24	0.51	0.26
Long-Term Deferred Tax Liabilities	-	-	0.33	0.35	0.3	0.16
Other Long-Term Liabilities	3.29	3.34	2.27	2.48	2.93	0.48
Total Liabilities	23.41	23.67	24.99	31.48	53.69	37.94
Common Stock	5.75	5.75	6.02	6.02	6.02	5.98
Additional Paid-In Capital	9.73	9.73	9.21	9.21	9.21	9.16
Retained Earnings	3.95	4.48	-5.93	2.26	22.66	-3.65
Treasury Stock	-	-	-0.42	-0.21	-0.24	-0.15
Comprehensive Income & Other	2.63	2.63	25.82	23.72	1.06	4.67
Total Common Equity	22.06	22.59	34.7	41	38.71	16.02
Minority Interest	-	-	0.18	0.24	0.22	0.02
Shareholders' Equity	22.06	22.59	34.88	41.24	38.93	16.04
Total Liabilities & Equity	45.47	46.26	59.87	72.72	92.62	53.98
Total Debt	9.04	10.02	12.84	15.53	17.76	20.02
Net Cash (Debt)	9.63	8.83	13.96	16.33	-2.02	-14.9
Net Cash Growth	-7.24%	-36.79%	-14.49%	-	-	-
Net Cash Per Share	-	3.10	4.64	4.56	-0.56	-4.98
Filing Date Shares Outstanding	-	2.85	2.92	2.99	2.98	2.75
Total Common Shares Outstanding	-	2.85	2.92	2.99	2.98	2.75
Working Capital	24.79	24.05	42.39	50.99	49.81	12.48
Book Value Per Share	-	7.93	11.87	13.71	13.00	5.83
Tangible Book Value	22.04	22.56	32.07	38.23	34.86	11.02
Tangible Book Value Per Share	-	7.92	10.97	12.78	11.71	4.01
Land	-	-	0.32	0.32	0.32	0.32
Buildings	-	-	3.56	3.51	3.77	3.8
Machinery	-	-	7.04	6.61	8.52	8.56
Construction In Progress	-	-	0.11	0.1	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.